Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Psychological strategies for discontinuing benzodiazepine treatment
Autore:
Spiegel, DA;
Indirizzi:
Boston Univ, Ctr Anxiety & Related Disorders, Boston, MA 02215 USA Boston Univ Boston MA USA 02215 & Related Disorders, Boston, MA 02215 USA
Titolo Testata:
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
fascicolo: 6, volume: 19, anno: 1999, supplemento:, 2
pagine: 17S - 22S
SICI:
0271-0749(199912)19:6<17S:PSFDBT>2.0.ZU;2-S
Fonte:
ISI
Lingua:
ENG
Soggetto:
COGNITIVE-BEHAVIOR THERAPY; PANIC DISORDER; ALPRAZOLAM DISCONTINUATION; DEPENDENCE; AGORAPHOBIA; WITHDRAWAL; EXPOSURE; MISINTERPRETATION; MANAGEMENT; EFFICACY;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
38
Recensione:
Indirizzi per estratti:
Indirizzo: Spiegel, DA Boston Univ, Ctr Anxiety & Related Disorders, 648 Beacon St,6th Floor, Boston, MA 02215 USA Boston Univ 648 Beacon St,6th Floor Boston MAUSA 02215 15 USA
Citazione:
D.A. Spiegel, "Psychological strategies for discontinuing benzodiazepine treatment", J CL PSYCH, 19(6), 1999, pp. 17S-22S

Abstract

Successful discontinuation of therapeutic drugs requires patients to negotiate two potentially difficult phases, First, they must complete the drug discontinuation procedure itself, which may entail coping with rebound and withdrawal symptoms as well as anxiety due to stopping a treatment on which they depend psychologically, Second, they must maintain drug abstinence over time, despite possible exacerbations or recurrences of the disorder that the drug was treating. For optimal success, interventions aimed at assisting patients to discontinue drug use must address both of those tasks, Patients' ability to discontinue benzodiazepines seems to be strongly influenced by cognitive appraisals of the threat represented by symptoms and of their own competence to cope with it without medication. For problems of that kind, cognitive and behavioral techniques such as those developed for the treatment of panic disorder may be especially well-suited. Currently, the most successful approaches to benzodiazepine discontinuation include the following components: (1) assisting with initial drug discontinuation, educating patients about benzodiazepine dependence and withdrawal, and about the kindsof symptoms that can emerge as the drug dose is decreased, combined with aflexible drug taper conducted in supportive collaboration with the patient; and (2) dealing with exacerbations of the illness, and providing disorder-specific cognitive-behavioral treatment as an alternative to the resumption of pharmacotherapy, It seems to be crucial that the drug taper be completed before psychological treatment concludes.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/09/20 alle ore 21:14:41